FusionGDB Logo

Home

Download

Statistics

Examples

Help

Contact
Center for Computational Systems Medicine
leaf

Fusion Gene Summary

leaf

Fusion Gene ORF analysis

leaf

Fusion Genomic Features

leaf

Fusion Protein Features

leaf

Fusion Gene Sequence

leaf

Fusion Gene PPI analysis

leaf

Related Drugs

leaf

Related Diseases

Fusion gene:ENO1-COL4A2 (FusionGDB2 ID:26547)

Fusion Gene Summary for ENO1-COL4A2

check button Fusion gene summary
Fusion gene informationFusion gene name: ENO1-COL4A2
Fusion gene ID: 26547
HgeneTgene
Gene symbol

ENO1

COL4A2

Gene ID

2023

1284

Gene nameenolase 1collagen type IV alpha 2 chain
SynonymsENO1L1|HEL-S-17|MPB1|NNE|PPHBSVD2|ICH|POREN2
Cytomap

1p36.23

13q34

Type of geneprotein-codingprotein-coding
Descriptionalpha-enolasec-myc promoter-binding protein-12-phospho-D-glycerate hydro-lyaseMYC promoter-binding protein 1alpha enolase like 1enolase 1, (alpha)enolase-alphaepididymis secretory protein Li 17non-neural enolasephosphopyruvate hydrataseplasminogcollagen alpha-2(IV) chaincanstatin
Modification date2020032020200313
UniProtAcc

P06733

P08572

Ensembl transtripts involved in fusion geneENST00000234590, ENST00000360467, 
ENST00000462309, 
Fusion gene scores* DoF score31 X 31 X 10=96109 X 10 X 5=450
# samples 448
** MAII scorelog2(44/9610*10)=-4.44896100213645
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0		log2(8/450*10)=-2.49185309632967
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Context

PubMed: ENO1 [Title/Abstract] AND COL4A2 [Title/Abstract] AND fusion [Title/Abstract]

Most frequent breakpointENO1(8926485)-COL4A2(111125307), # samples:1
Anticipated loss of major functional domain due to fusion event.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneENO1

GO:0000122

negative regulation of transcription by RNA polymerase II

2005901

HgeneENO1

GO:0030308

negative regulation of cell growth

10082554

HgeneENO1

GO:0045892

negative regulation of transcription, DNA-templated

10082554

HgeneENO1

GO:0061621

canonical glycolysis

29775581

HgeneENO1

GO:1903298

negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway

15459207

HgeneENO1

GO:2001171

positive regulation of ATP biosynthetic process

15459207

TgeneCOL4A2

GO:0016525

negative regulation of angiogenesis

10625665


check buttonFusion gene breakpoints across ENO1 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.

check buttonFusion gene breakpoints across COL4A2 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.

check button Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0)
* All genome coordinats were lifted-over on hg19.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
SourceDiseaseSampleHgeneHchrHbpHstrandTgeneTchrTbpTstrand
ChiTaRS5.0N/AAW362574ENO1chr1

8926485

+COL4A2chr13

111125307

-


Top

Fusion Gene ORF analysis for ENO1-COL4A2

check button Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
ORFHenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrand
intron-3CDSENST00000234590ENST00000360467ENO1chr1

8926485

+COL4A2chr13

111125307

-
intron-intronENST00000234590ENST00000462309ENO1chr1

8926485

+COL4A2chr13

111125307

-

check buttonORFfinder result based on the fusion transcript sequence of in-frame fusion genes.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)		BP loci
(transcript)		Predicted start
(transcript)		Predicted stop
(transcript)		Seq length
(amino acids)

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score

Top

Fusion Genomic Features for ENO1-COL4A2


check buttonFusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints.
HgeneHchrHbpHstrandTgeneTchrTbpTstrand1-pp (fusion gene breakpoint)

check buttonDistribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page.

check buttonDistribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page.

Top

Fusion Protein Features for ENO1-COL4A2


check button Go to

FGviewer for the breakpoints of :-:

.
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
FGviewer

check buttonMain function of each fusion partner protein. (from UniProt)
HgeneTgene
ENO1

P06733

COL4A2

P08572

FUNCTION: Glycolytic enzyme the catalyzes the conversion of 2-phosphoglycerate to phosphoenolpyruvate (PubMed:29775581, PubMed:1369209). In addition to glycolysis, involved in various processes such as growth control, hypoxia tolerance and allergic responses (PubMed:2005901, PubMed:10802057, PubMed:12666133, PubMed:29775581). May also function in the intravascular and pericellular fibrinolytic system due to its ability to serve as a receptor and activator of plasminogen on the cell surface of several cell-types such as leukocytes and neurons (PubMed:12666133). Stimulates immunoglobulin production (PubMed:1369209). {ECO:0000269|PubMed:10802057, ECO:0000269|PubMed:12666133, ECO:0000269|PubMed:1369209, ECO:0000269|PubMed:2005901, ECO:0000269|PubMed:29775581}.; FUNCTION: MBP1 binds to the myc promoter and acts as a transcriptional repressor. May be a tumor suppressor. {ECO:0000269|PubMed:10082554}.FUNCTION: Type IV collagen is the major structural component of glomerular basement membranes (GBM), forming a 'chicken-wire' meshwork together with laminins, proteoglycans and entactin/nidogen.; FUNCTION: Canstatin, a cleavage product corresponding to the collagen alpha 2(IV) NC1 domain, possesses both anti-angiogenic and anti-tumor cell activity. It inhibits proliferation and migration of endothelial cells, reduces mitochondrial membrane potential, and induces apoptosis. Specifically induces Fas-dependent apoptosis and activates procaspase-8 and -9 activity. Ligand for alphavbeta3 and alphavbeta5 integrins.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at

download page


* Minus value of BPloci means that the break pointn is located before the CDS.
- In-frame and retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

- In-frame and not-retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note


Top

Fusion Gene Sequence for ENO1-COL4A2


check button For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones.

Top

Fusion Gene PPI Analysis for ENO1-COL4A2


check button Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in

ChiPPI page.


check button Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160)
HgeneHgene's interactorsTgeneTgene's interactors


check button - Retained PPIs in in-frame fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenStill interaction with


check button - Lost PPIs in in-frame fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with


check button - Retained PPIs, but lost function due to frame-shift fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with


Top

Related Drugs for ENO1-COL4A2


check button Drugs targeting genes involved in this fusion gene.
(DrugBank Version 5.1.8 2021-05-08)
PartnerGeneUniProtAccDrugBank IDDrug nameDrug activityDrug typeDrug status
HgeneENO1P06733DB14548Zinc sulfate, unspecified formBinderSmall moleculeApproved|Experimental
HgeneENO1P06733DB14548Zinc sulfate, unspecified formBinderSmall moleculeApproved|Experimental
HgeneENO1P06733DB14548Zinc sulfate, unspecified formBinderSmall moleculeApproved|Experimental
HgeneENO1P06733DB14548Zinc sulfate, unspecified formBinderSmall moleculeApproved|Experimental
HgeneENO1P06733DB01593ZincSmall moleculeApproved|Investigational
HgeneENO1P06733DB01593ZincSmall moleculeApproved|Investigational
HgeneENO1P06733DB01593ZincSmall moleculeApproved|Investigational
HgeneENO1P06733DB01593ZincSmall moleculeApproved|Investigational
HgeneENO1P06733DB09130CopperSmall moleculeApproved|Investigational
HgeneENO1P06733DB09130CopperSmall moleculeApproved|Investigational
HgeneENO1P06733DB09130CopperSmall moleculeApproved|Investigational
HgeneENO1P06733DB09130CopperSmall moleculeApproved|Investigational
HgeneENO1P06733DB14487Zinc acetateSmall moleculeApproved|Investigational
HgeneENO1P06733DB14487Zinc acetateSmall moleculeApproved|Investigational
HgeneENO1P06733DB14487Zinc acetateSmall moleculeApproved|Investigational
HgeneENO1P06733DB14487Zinc acetateSmall moleculeApproved|Investigational
HgeneENO1P06733DB14533Zinc chlorideBinderSmall moleculeApproved|Investigational
HgeneENO1P06733DB14533Zinc chlorideBinderSmall moleculeApproved|Investigational
HgeneENO1P06733DB14533Zinc chlorideBinderSmall moleculeApproved|Investigational
HgeneENO1P06733DB14533Zinc chlorideBinderSmall moleculeApproved|Investigational

Top

Related Diseases for ENO1-COL4A2


check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource
HgeneENO1C0019193Hepatitis, Toxic2CTD_human
HgeneENO1C0152013Adenocarcinoma of lung (disorder)2CTD_human
HgeneENO1C0860207Drug-Induced Liver Disease2CTD_human
HgeneENO1C1262760Hepatitis, Drug-Induced2CTD_human
HgeneENO1C3658290Drug-Induced Acute Liver Injury2CTD_human
HgeneENO1C4277682Chemical and Drug Induced Liver Injury2CTD_human
HgeneENO1C4279912Chemically-Induced Liver Toxicity2CTD_human
HgeneENO1C0001418Adenocarcinoma1CTD_human
HgeneENO1C0001787Osteoporosis, Age-Related1CTD_human
HgeneENO1C0002395Alzheimer's Disease1CTD_human
HgeneENO1C0003873Rheumatoid Arthritis1CTD_human
HgeneENO1C0006142Malignant neoplasm of breast1CTD_human
HgeneENO1C0007097Carcinoma1CTD_human
HgeneENO1C0007131Non-Small Cell Lung Carcinoma1CTD_human
HgeneENO1C0007137Squamous cell carcinoma1CTD_human
HgeneENO1C0011265Presenile dementia1CTD_human
HgeneENO1C0014859Esophageal Neoplasms1CTD_human
HgeneENO1C0021364Male infertility1CTD_human
HgeneENO1C0024623Malignant neoplasm of stomach1CTD_human
HgeneENO1C0024667Animal Mammary Neoplasms1CTD_human
HgeneENO1C0024668Mammary Neoplasms, Experimental1CTD_human
HgeneENO1C0026640Mouth Neoplasms1CTD_human
HgeneENO1C0027626Neoplasm Invasiveness1CTD_human
HgeneENO1C0029408Degenerative polyarthritis1CTD_human
HgeneENO1C0029456Osteoporosis1CTD_human
HgeneENO1C0029459Osteoporosis, Senile1CTD_human
HgeneENO1C0038356Stomach Neoplasms1CTD_human
HgeneENO1C0086743Osteoarthrosis Deformans1CTD_human
HgeneENO1C0153381Malignant neoplasm of mouth1CTD_human
HgeneENO1C0205641Adenocarcinoma, Basal Cell1CTD_human
HgeneENO1C0205642Adenocarcinoma, Oxyphilic1CTD_human
HgeneENO1C0205643Carcinoma, Cribriform1CTD_human
HgeneENO1C0205644Carcinoma, Granular Cell1CTD_human
HgeneENO1C0205645Adenocarcinoma, Tubular1CTD_human
HgeneENO1C0205696Anaplastic carcinoma1CTD_human
HgeneENO1C0205697Carcinoma, Spindle-Cell1CTD_human
HgeneENO1C0205698Undifferentiated carcinoma1CTD_human
HgeneENO1C0205699Carcinomatosis1CTD_human
HgeneENO1C0276496Familial Alzheimer Disease (FAD)1CTD_human
HgeneENO1C0494463Alzheimer Disease, Late Onset1CTD_human
HgeneENO1C0520459Necrotizing Enterocolitis1CTD_human
HgeneENO1C0546126Acute Confusional Senile Dementia1CTD_human
HgeneENO1C0546837Malignant neoplasm of esophagus1CTD_human
HgeneENO1C0678222Breast Carcinoma1CTD_human
HgeneENO1C0750900Alzheimer's Disease, Focal Onset1CTD_human
HgeneENO1C0750901Alzheimer Disease, Early Onset1CTD_human
HgeneENO1C0751406Post-Traumatic Osteoporosis1CTD_human
HgeneENO1C0848676Subfertility, Male1CTD_human
HgeneENO1C0917731Male sterility1CTD_human
HgeneENO1C0948089Acute Coronary Syndrome1CTD_human
HgeneENO1C1257925Mammary Carcinoma, Animal1CTD_human
HgeneENO1C1257931Mammary Neoplasms, Human1CTD_human
HgeneENO1C1458155Mammary Neoplasms1CTD_human
HgeneENO1C1708349Hereditary Diffuse Gastric Cancer1CTD_human
HgeneENO1C2239176Liver carcinoma1CTD_human
HgeneENO1C4704874Mammary Carcinoma, Human1CTD_human
TgeneCOL4A2C3280970PORENCEPHALY 24GENOMICS_ENGLAND;UNIPROT
TgeneCOL4A2C0023893Liver Cirrhosis, Experimental1CTD_human
TgeneCOL4A2C0027726Nephrotic Syndrome1CTD_human
TgeneCOL4A2C0149925Small cell carcinoma of lung1CTD_human
TgeneCOL4A2C3281105HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO1GENOMICS_ENGLAND
TgeneCOL4A2C4082173Porencephaly1CTD_human;GENOMICS_ENGLAND